RXST RXSIGHT INC revenue, earnings and financials

For the quarter ended June 30, 2026, RXSIGHT INC reported revenue of $33.7M (up 0.3% from a year earlier), net income of −$12.1M and diluted EPS of −$0.29; over the last four quarters revenue was $128M and net income −$8.01M; for the fiscal year ended December 2025 revenue was $134M, down 3.9% on the year before.

RXST annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $134M, gross profit $103M, operating income −$48.2M, net income −$39 (margin 0.0%), EPS −$0.95
• Fiscal year ended Dec 2024: revenue $140M, gross profit $98.9M, operating income −$36.9M, net income −$28 (margin 0.0%), EPS −$0.71
• Fiscal year ended Dec 2023: revenue $89.1M, gross profit $53.8M, operating income −$50.1M, net income −$49 (margin 0.0%), EPS −$1.41
• Fiscal year ended Dec 2022: revenue $49.0M, gross profit $21.3M, operating income −$63.3M, net income −$67 (margin 0.0%), EPS −$2.41
• Fiscal year ended Dec 2021: revenue $22.6M, gross profit $4.52M, operating income −$52.8M, net income −$48.7M (margin -215.5%), EPS −$3.57

RXST quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $33.7M (up 0.3% year over year), net income −$12.1M, EPS −$0.29
• Quarter ended Mar 31, 2026: revenue $30.9M (down 18.5% year over year), net income −$15.9M, EPS −$0.38
• Quarter ended Dec 31, 2025 (from the annual report): revenue $32.6M (down 18.9% year over year), net income $29.8M, EPS −$0.22
• Quarter ended Sep 30, 2025: revenue $30.3M (down 14.1% year over year), net income −$9.82M, EPS −$0.24
• Quarter ended Jun 30, 2025: revenue $33.6M (down 3.6% year over year), net income −$11.8M, EPS −$0.29
• Quarter ended Mar 31, 2025: revenue $37.9M (up 28.4% year over year), net income −$8.19M, EPS −$0.20
• Quarter ended Dec 31, 2024 (from the annual report): revenue $40.2M (up 40.7% year over year), net income $21.5M, EPS −$0.14
• Quarter ended Sep 30, 2024: revenue $35.3M (up 59.1% year over year), net income −$6.34M, EPS −$0.16
• Quarter ended Jun 30, 2024: revenue $34.9M (up 67.6% year over year), net income −$6.08M, EPS −$0.16
• Quarter ended Mar 31, 2024: revenue $29.5M (up 68.7% year over year), net income −$9.10M, EPS −$0.25
• Quarter ended Dec 31, 2023 (from the annual report): revenue $28.6M (up 77.6% year over year), net income $39.4M, EPS −$0.24
• Quarter ended Sep 30, 2023: revenue $22.2M (up 76.0% year over year), net income −$12.4M, EPS −$0.35
• Quarter ended Jun 30, 2023: revenue $20.8M (up 83.2% year over year), net income −$13.8M, EPS −$0.40
• Quarter ended Mar 31, 2023: revenue $17.5M (up 95.6% year over year), net income −$13.2M, EPS −$0.42
• Quarter ended Dec 31, 2022 (from the annual report): revenue $16.1M (up 90.9% year over year), net income $51.1M, EPS −$0.55
• Quarter ended Sep 30, 2022: revenue $12.6M (up 118.0% year over year), net income −$16.8M, EPS −$0.61
• Quarter ended Jun 30, 2022: revenue $11.4M (up 132.0% year over year), net income −$16.7M, EPS −$0.61
• Quarter ended Mar 31, 2022: revenue $8.94M (up 156.7% year over year), net income −$17.6M, EPS −$0.64
• Quarter ended Dec 31, 2021 (from the annual report): revenue $8.43M, net income −$15.7M, EPS $2.34
• Quarter ended Sep 30, 2021: revenue $5.79M, net income −$12.7M, EPS −$0.68

RXST cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$15.5M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$16.9M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$41.6M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow −$58.9M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$44.7M, share buybacks n/a

RXST balance sheet

• Jun 30, 2026: cash $13.4M, total assets $353M, total liabilities $89.4M, shareholders' equity $263M
• Mar 31, 2026: cash $17.6M, total assets $304M, total liabilities $36.7M, shareholders' equity $267M
• Dec 31, 2025: cash $19.9M, total assets $312M, total liabilities $36.1M, shareholders' equity $276M
• Sep 30, 2025: cash $29.6M, total assets $309M, total liabilities $32.6M, shareholders' equity $276M
• Jun 30, 2025: cash $40.4M, total assets $309M, total liabilities $31.0M, shareholders' equity $278M
• Mar 31, 2025: cash $28.0M, total assets $313M, total liabilities $33.7M, shareholders' equity $279M
• Dec 31, 2024: cash $16.7M, total assets $319M, total liabilities $37.3M, shareholders' equity $281M
• Sep 30, 2024: cash $16.7M, total assets $310M, total liabilities $33.2M, shareholders' equity $277M

What is RXST's revenue?

RXSIGHT INC reported $128M of revenue over its last four quarters, through June 30, 2026.

Is RXST profitable?

No. RXSIGHT INC lost $8.01M over the last four quarters.

What is RXST's EPS?

Diluted earnings per share over the last four quarters were −$1.13; −$0.29 in the latest quarter.

RXST ownership and insider trades · All stocks